SE8305467D0 - 1,4-dihydropyridinderivat - Google Patents
1,4-dihydropyridinderivatInfo
- Publication number
- SE8305467D0 SE8305467D0 SE8305467A SE8305467A SE8305467D0 SE 8305467 D0 SE8305467 D0 SE 8305467D0 SE 8305467 A SE8305467 A SE 8305467A SE 8305467 A SE8305467 A SE 8305467A SE 8305467 D0 SE8305467 D0 SE 8305467D0
- Authority
- SE
- Sweden
- Prior art keywords
- carbon atoms
- nitratoalkyl
- compounds
- artery disease
- dihydropyridine
- Prior art date
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical compound C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 208000021910 Cerebral Arterial disease Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57067759A JPS58185562A (ja) | 1982-04-22 | 1982-04-22 | １，４−ジヒドロピリジン誘導体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE8305467D0 true SE8305467D0 (sv) | 1983-10-05 |
| SE8305467L SE8305467L (sv) | 1985-04-06 |
| SE440648B SE440648B (sv) | 1985-08-12 |
Family
ID=13354183
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8305467A SE440648B (sv) | 1982-04-22 | 1983-10-05 | 1,4-dihydropyridin-dikarboxylsyra-nitratoalkylestrar |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US4472411A (sv) |
| EP (1) | EP0092936B1 (sv) |
| JP (1) | JPS58185562A (sv) |
| AU (1) | AU565424B2 (sv) |
| BE (1) | BE898024A (sv) |
| DE (1) | DE3370620D1 (sv) |
| NL (1) | NL8303616A (sv) |
| SE (1) | SE440648B (sv) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3244178A1 (de) * | 1982-11-30 | 1984-05-30 | Bayer Ag, 5090 Leverkusen | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln |
| EP0127150A3 (en) * | 1983-05-27 | 1987-07-22 | Fujisawa Pharmaceutical Co., Ltd. | 2,6-disubstituted-1,4-dihydropyridine derivative, process for the preparation of the same and pharmaceutical composition comprising the same |
| GB8314744D0 (en) * | 1983-05-27 | 1983-07-06 | Fujisawa Pharmaceutical Co | 2 6-disubstituted-1 4-dihydropyridine derivative |
| JPS60156671A (ja) * | 1984-01-25 | 1985-08-16 | Yamanouchi Pharmaceut Co Ltd | ジヒドロピリジン誘導体およびその製造法 |
| US4730052A (en) * | 1984-07-13 | 1988-03-08 | Taisho Pharmaceutical Co., Ltd. | Method for preparing unsymmetrical 1,4-dihydropyridine-3,5-dicarboxylic acid diesters |
| JPS6289662A (ja) | 1985-06-14 | 1987-04-24 | Sankyo Co Ltd | １，４−ジヒドロピリジン誘導体 |
| JPS62174050A (ja) * | 1985-10-21 | 1987-07-30 | Nippon Shoji Kk | ３−アミノカルボニル−１，４−ジヒドロピリジン−５−カルボン酸誘導体、その製法および医薬組成物 |
| US4780538A (en) * | 1986-02-12 | 1988-10-25 | Merck & Co., Inc. | Process for 1,4-dihydropyridine compounds using a titanamine catalyst |
| JPS62292757A (ja) * | 1986-06-12 | 1987-12-19 | Taisho Pharmaceut Co Ltd | １，４−ジヒドロピリジン誘導体 |
| JPS6396126A (ja) * | 1986-10-13 | 1988-04-27 | Taisho Pharmaceut Co Ltd | 安定化組成物 |
| US5047543A (en) * | 1988-11-24 | 1991-09-10 | Taisho Pharmaceutical Co., Ltd. | 1,4-dihydropyridine derivatives |
| NL9001752A (nl) * | 1990-08-02 | 1992-03-02 | Cedona Pharm Bv | Nieuwe 1,4-dihydropyridinederivaten. |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| EP1889198B1 (en) | 2005-04-28 | 2014-11-26 | Proteus Digital Health, Inc. | Pharma-informatics system |
| WO2008036682A2 (en) | 2006-09-18 | 2008-03-27 | Raptor Pharmaceutical Inc. | Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates |
| DK3395372T3 (da) | 2009-02-20 | 2022-04-19 | Enhanx Biopharm Inc | System til afgivelse af glutathion-baseret medikament |
| EP2427178B1 (en) | 2009-05-06 | 2023-01-04 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1670827C3 (de) * | 1967-03-20 | 1974-10-24 | Bayer Ag, 5090 Leverkusen | 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin |
| DE2117573C3 (de) * | 1971-04-10 | 1978-07-27 | Bayer Ag, 5090 Leverkusen | Verfahren zur Herstellung von unsymmetrischen l,4-Dihydropyridin-3,5dicarbonsäureestern, sowie ihre Verwendung als Arzneimittel |
| DE2847236A1 (de) * | 1978-10-31 | 1980-05-14 | Bayer Ag | Neue dihydropyridine mit substituierten estergruppierungen, mehrer verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1982
- 1982-04-22 JP JP57067759A patent/JPS58185562A/ja active Granted
-
1983
- 1983-04-13 DE DE8383302075T patent/DE3370620D1/de not_active Expired
- 1983-04-13 EP EP83302075A patent/EP0092936B1/en not_active Expired
- 1983-04-19 US US06/486,508 patent/US4472411A/en not_active Expired - Fee Related
- 1983-10-05 SE SE8305467A patent/SE440648B/sv not_active IP Right Cessation
- 1983-10-06 AU AU19941/83A patent/AU565424B2/en not_active Ceased
- 1983-10-19 BE BE0/211728A patent/BE898024A/fr not_active IP Right Cessation
- 1983-10-20 NL NL8303616A patent/NL8303616A/nl not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE3370620D1 (en) | 1987-05-07 |
| JPS635024B2 (sv) | 1988-02-01 |
| SE8305467L (sv) | 1985-04-06 |
| EP0092936B1 (en) | 1987-04-01 |
| EP0092936A1 (en) | 1983-11-02 |
| US4472411A (en) | 1984-09-18 |
| JPS58185562A (ja) | 1983-10-29 |
| BE898024A (fr) | 1984-04-19 |
| SE440648B (sv) | 1985-08-12 |
| AU565424B2 (en) | 1987-09-17 |
| AU1994183A (en) | 1985-04-18 |
| NL8303616A (nl) | 1985-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8305467L (sv) | 1,4-dihydropyridinderivat | |
| IL116122A0 (en) | Intermediates to heterocyclic-cyclic amine derivatives | |
| DE122006000010I1 (de) | Benzocyclobutyl- oder Indanyl-Alkyl-Amino-Alkyl substituierte 3- Benzazepin-2-ones, verwendbar in der Behandlung von kardiovaskularen Krankheiten | |
| FR2383171A1 (fr) | Derives de thiopropanoylaminoacides utiles comme hypotenseurs | |
| ES515081A0 (es) | "procedimiento para la preparacion de derivados de 6-metilprednisolona". | |
| FI822203A0 (fi) | Nya 2-aryl-3,4-diaza-bicyklo/4,n,0/-alken-(2)-oner-(5), foerfarande foer deras framstaellning och dessa innehaollande laekemedel | |
| FR2384745A1 (fr) | Derives de la somatostatine et leur preparation | |
| FR2389594A1 (sv) | ||
| NO891703D0 (no) | Farmasoeytiske sammensetninger for behandling av psoriasis. | |
| NZ217418A (en) | Tricyclic heterocyclic compounds and pharmaceutical compositions | |
| FI830397L (fi) | Foerfarande foer framstaellning av imidazolidinderivat | |
| FR2428045A1 (fr) | Derives silyles de naphtacenones utilisables notamment dans la synthese d'agents antitumeurs | |
| FR2389597A1 (sv) | ||
| DE3460834D1 (en) | Derivatives of bicyclo(4.2.0)octatriene-1,3,5, their preparation and their therapeutical application | |
| LV10234A (lv) | Trijodbenzola savienojumu iegusanas metode | |
| FR2389615A1 (sv) | ||
| NO842345L (no) | Heksahydropyrrolo(2,1-a)isoquinolin-derivater. | |
| ES501744A0 (es) | Procedimiento para la obtencion de bis (fenoxiacetatos sus- tituidos)de n-alcohil-dialcanolaminas | |
| FR2429202A1 (sv) | ||
| FR2428041A1 (fr) | Derives d'esters d'acides quinolopyranne-4-one-2-carboxyliques et application de ceux-ci comme antiasthmatiques antiallergiques | |
| DK416289D0 (da) | Estere af 3-demethylthiocolchicin og n-acylanaloger | |
| FR2381008A1 (fr) | Nouveaux patchoulols hydroxyles | |
| FR2420524A1 (fr) | Benzo-cyclitolamines et leurs utilisations therapeutiques comme agents hypotenseurs | |
| ES2002325A6 (es) | Un procedimiento para preparar un derivado de dihidropiridina | |
| FR2671552B1 (fr) | Procede de preparation de thiazolyl-2 oxamates d'alkyle. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 8305467-6 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 8305467-6 Format of ref document f/p: F |